Come up with a name for your new list and we'll add to it:
3-V Biosciences raised a round of funding on March 06, 2009. Investors include
Qualifying Therapeutic Discovery Project.
3-V Biosciences is discovering and developing therapeutics that modulate key pathways in oncology and infectious diseases. In oncology, the company's lead candidate is a fatty acid synthase (FASN) inh…